AusBiotech has always been for its members. Built by our members, to be the national voice of our sector we are proud to support our member's growth ...
AusBiotech has always been for its members. Built by our members, to be the national voice of our sector we are proud to support our member's growth ...
On August 23, 2024, the FDA approved Amgen’s aflibercept biosimilar PAVBLU (aflibercept-ayyh), a biosimilar of Regeneron’s EYLEA®. According to the approval letter, “Pavblu is indicated for ...
The contract's principal scope involves the design and construction of an 8.48 km tunnel with a bored diameter of 3,500 mm.
The inspection, which took place between September 23 and September 27, 2024, concluded with 4 observations from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback